D uring immune and inflammatory responses, the coordinate expression of chemokines and adhesion molecules orchestrates the migration of lymphocytes, monocytes, and dendritic cells between sites of infection or inflammation and secondary lymphoid organs (1) (2) (3) . Although the chemokines involved in directing leukocyte migration during inflammation, the initiation of cellular immunity, and wound healing have been studied for more than a decade (4, 5) , there are virtually no reports of chemokines involved in the migration of cells during the development of peripheral tolerance or active suppression.
The chemokine signals responsible for the directed migration of monocytes, macrophages, and T cells are well known, but the signals controlling NKT cell migration are not. NKT cells are unconventional T cells that express most NK cell markers and the CD1-restricted, canonical TCR. Upon stimulation of their TCR, NKT cells release remarkable amounts of cytokines. Although their biological role is still not entirely understood, NKT cells were originally proposed to bias the outcome of cellular immune responses (e.g., Th1 vs Th2) (6) and are now known to be defective or deficient in several autoimmune diseases (7, 8) , implying that they are crucial for the maintenance of peripheral tolerance to self-Ags.
In support of this, Sonoda and colleagues demonstrated that CD1-restricted NKT cells accumulate in the spleen and are required for the induction of T regulatory (Tr) 3 cells that convey peripheral tolerance following intraocular exposure to Ag (9) . We reasoned that NKT cell accumulation might result either from a local expansion of resident splenic NKT cells or through recruitment of NKT cells from the periphery. Insights into mechanisms that might induce peripheral tolerance to both self and foreign Ags are gathered from studies of immune-privileged sites. Perhaps the best studied immune-privileged site is the eye, using the anterior chamber-associated immune deviation (ACAID) model, where peripheral tolerance is induced following Ag inoculation in the anterior chamber (a.c.). ACAID is demonstrated experimentally by the inability of a.c.-inoculated mice to mount subsequent Ag-specific delayed-type hypersensitivity (DTH) responses in the periphery (9, 10) . In brief, ACAID requires the presence of an intact eye for the first 3 days and an intact spleen the next 4 -7 days following a.c. inoculation (10) and is mediated by Ag-specific negative regulatory CD8 ϩ T cells generated within the spleen during the first week of ACAID induction (11) . It is believed that an eye-derived F4/80 ϩ monocyte/macrophage appearing in the peripheral blood shortly after a.c. inoculation of Ag travels to the spleen, where it conveys Ag specificity and sets the stage for tolerance-producing mechanisms (12) . Evidence is presented in this report to support a unique role for monocyte/macrophagederived macrophage inflammatory protein (MIP)-2 in the migration of NKT cells to the site of tolerance induction (the spleen) after Ag is presented in the eye.
Traffic of lymphocytes to the spleen is less regulated than traffic through the lymph nodes in that blood-borne cells arriving in the spleen simply "pour out" of the central arterioles into the marginal zones around the periarteriolar lymphoid sheath (PALS) (13) . Because the terminal arterioles in the spleen do not end with a network of capillaries, the flow of cells is neither slowed nor regulated. Furthermore, adhesion molecules do not facilitate extravasation of immune cells into the spleen as they do in lymph nodes. It is known that cell clustering is necessary for Ag presentation, the induction of primed T cell responses, and the generation of Ab responses (14) . Confocal microscopy studies presented here show that F4/80 ϩ monocytes/macrophages, NKT cells, and conventional CD3 ϩ T cells similarly cluster in the marginal zones of the spleen during the induction of peripheral tolerance. Taken together, our results show that a specific chemokine, MIP-2, mediates the recruitment of NKT cells to a secondary lymphoid organ where they colocalize with newly arrived F4/80 ϩ cells and conventional T cells to induce active suppression.
Materials and Methods

Mice
Female BALB/cAnNTac, C57BL/6, and MHC class II knockout mice (ABBN.5) used in these experiments were obtained from the Schepens Eye Research Institute Vivarium or from Taconic Farms (Taconic, NY). Female Cmkar2 tm1Mwm (CXCR2-deficient) mice were obtained from The Jackson Laboratory (Bar Harbor, ME). Mice were housed on a 12/12-h light/dark cycle and provided with food and water ad libitum. All animals were treated humanely and in accordance with the guidelines set forth by the Schepens Eye Research Institute Animal Care and Use Committee and the National Institutes of Health.
Anterior chamber inoculation of Ag
Ags were administered into the a.c. of mice anesthetized with ketamine/ xylazine. Briefly, the cornea was punctured with a 30-gauge needle, and the aqueous humor (ϳ2 l) was drained. The anterior segment of the eye was then re-inflated with ϳ2 l of air. Using finely drawn glass needles, 50 g of OVA (2 l of a 25-mg/ml solution in HBSS) was instilled into the a.c., displacing the air. The OVA solutions used in these studies were passed through DetoxiGel AffinityPak polymixin B columns (Pierce, Rockford, IL) to remove contaminating endotoxin/LPS (98% efficiency of endotoxin removal of concentrations up to 2 mg/ml).
Cell enrichment
PBMCs used in the RNA analyses were isolated from heparinized venous blood obtained at 1, 3, 5, and 7 days after a.c. inoculation of Ag. PBMCs were enriched by density gradient centrifugation using Lympholyte-M (Cedarlane Laboratories, Hornby, Ontario, Canada) according to the manufacturer's protocol. NKT cells used in the chemotaxis and RT-PCR assays were enriched from the spleens of naive MHC class II knockout mice on the B6 background by FACS (Becton Dickinson, Mountain View, CA) sorting as previously described (9) . The purity of FACS-sorted NKT cells was ϳ94%. Splenic T cells used for the local adoptive transfer (LAT) assay (described below) were enriched using IMMULAN T cell enrichment columns (Biotecx Laboratories, Houston, TX).
Cell lines
Macrophage hybridoma cell lines 59 and 63, originally described by Ishikura et al. (15) , were maintained in RPMI 1640, 10% FCS (Life Technologies, Gaithersburg, MD). For all experiments described here, cells were cultured in serum-free medium (SFM) consisting of RPMI 1640, 10 mM HEPES, 0.1 mM nonessential amino acids, 1 mM sodium pyruvate, 100 U/ml penicillin, and 100 g/ml streptomycin (all from Life Technologies), supplemented with 0.1% BSA and ITS ϩ culture supplement (1 g/ml iron-free transferrin, 10 ng/ml linoleic acid, 0.3 ng/ml Na 2 Se, and 0.2 g/ml Fe(NO 3 ) 3 ) (Collaborative Biomedical, Medford, MA).
Isolation and analysis of chemokine mRNA
Total cellular RNA was isolated from different cell types using TRIzol reagent (Life Technologies). RNA isolation was performed according to the manufacturer's protocol. Chemokine mRNA was analyzed with the RiboQuant multiprobe RNase protection assay and the mCK-5 mouse chemokine riboprobe template set (PharMingen-BD Biosciences, San Diego, CA) encoding lymphotactin (Ltn), RANTES, eotaxin, MIP-1␣ and ␤, MIP-2, inflammatory protein 10 (IP-10), monocyte chemoattractant protein (MCP)-1, TCA-3, L32, and GAPDH. Total RNA (2-5 g) was used for the RNase protection assay (RPA), followed by electrophoresis on polyacrylamide sequencing gels. The gels were dried at 80°C for 1 h. mRNA bands were detected by phosphorimaging with a Bio-Rad Molecular FX Imaging system (Bio-Rad, Hercules, CA) and quantified with QuantiOne Molecular Imaging Software (Bio-Rad). To compensate for loading imperfections and for quantitative purposes, chemokine mRNA bands were normalized to GAPDH bands. Scanning densitometry results are expressed as arbitrary OD units (OD x /OD GAPDH , where "x" is the OD of the chemokine band of interest).
Chemotaxis assays
To examine the ability of NKT cells to respond to chemokines (i.e., to MIP-2), Boyden chamber chemotaxis assays were performed according to a modified method from Current Protocols in Immunology (16) . Briefly, the bottom wells of a 48-well Poretics Boyden chamber (Osmonics, Livermore, CA) were loaded with SFM in the presence or absence of recombinant murine MIP-2 (R&D Systems, Minneapolis, MN) in a total volume of 28 -30 l, while the lower wells contained 2 ϫ 10 4 NKT cells. The upper and lower segments of the chamber were assembled with an intervening collagen-treated polycarbonate membrane (8-M pore size; Osmonics) and incubated (37°C, 5% CO 2 in air) for 8 -12 h. The membranes were air dried and stained with Diff-Quick (VWR Scientific Products, Bridgeport, NJ), and the relative amount of chemotaxis was determined by counting the number of cells that had crossed the membrane within the area of a high-power field containing a 10 ϫ 10 eyepiece grid (five high-power fields per well).
RT-PCR
Total cellular RNA was isolated from murine L-DAP fibroblasts, sodium caseinate-elicited murine peritoneal neutrophils, DN32.D3 NKT hybridoma cells, and FACS-sorted NKT and CD8 T cells. One hundred nanograms of total RNA was reverse transcribed and amplified using the Access RT-PCR system (Promega, Madison, WI) according to the manufacturer's specifications. RT-PCR products were resolved by electrophoresis in a 1.5% agarose gel containing GelStar nucleic acid stain (FMC BioProducts, Rockland, ME). The bands were visualized and the gels were photographed using a Molecular FX Imaging station and GelDoc (both from Bio-Rad). The primers used were as follows: murine CXCR2, sense 5Ј-GTC TAC CTG CTG AAC CTG GCC-3Ј, antisense 5Ј-GGT TGT AGG GCA GCC-3Ј; murine ␤-actin, sense 5Ј-GTG GGC CGC TCT AGG CAC CAA-3Ј, antisense 5Ј-CTC TTT GAT TGC ACG CAC GAT TTC-3Ј.
Antibodies
The Abs used for flow cytometry were as follows: biotin-conjugated NK1.1 (PK136); FITC-conjugated CD3⑀; Cy5-conjugated TCR ␤-chain (all from PharMingen-BD Biosciences); and streptavidin-conjugated R-PE (Jackson ImmunoResearch, West Grove, PA). The primary Abs used for confocal microscopy studies were as follows: rat anti-mouse F4/80 (Caltag, Burlingame, CA); biotin-conjugated anti-NK1.1 (hybridoma clone PK136; American Type Culture Collection, Manassas, VA); and hamster antimouse CD3⑀ (PharMingen-BD Biosciences). The secondary reagents used for confocal microscopy studies were Cy-5-conjugated goat anti-rat F(abЈ) 2 ; Rhodamine RedX-conjugated goat anti-Armenian hamster IgG (HϩL) (Jackson ImmunoResearch); and ExtrAvidin FITC conjugate (Sigma, St. Louis, MO). The Abs used for in vivo assays were as follows: rat anti-mouse MIP-2 (MAB452, clone 40605.111; R&D Systems) and rat IgG (Sigma). Abs delivered in vivo were suspended in 100 l sterile PBS and injected i.p. (50 g per mouse, total dose).
Flow cytometric evaluation of NKT cells
Flow cytometric analyses were performed as previously described (9) 
LAT assay
LAT was used to test for the presence or absence of regulatory CD8 ϩ T cells as previously described (9, 17) . Briefly, OVA-primed effector T cells were generated by immunizing C57BL/6 mice with OVA in CFA (Sigma). Seven days later, the spleens were collected and enriched for T cells by passage over IMMULAN columns (Biotecx Laboratories). Tr cells were enriched from the spleens of mice that received anti-MIP-2 mAb or control IgG (i.p.) 7 days post-OVA or -HBSS (a.c.). Stimulator cells were obtained by culturing thioglycollate-elicited peritoneal exudate cells (PECs) with OVA (5 ng/ml) overnight. Stimulator, effector, and regulatory cells (5 ϫ 10 5 each) were resuspended in 10 l HBSS and injected intradermally into the ear pinnae of completely naive mice. The change in ear thickness was measured at 24 and 48 h after ear challenge using an engineer's micrometer (Mitutoyo, Paramus, NJ).
Confocal microscopy
To examine the anatomical distribution of NKT cells in the spleen relative to the F4/80 ϩ APCs and conventional T cells, OVA-(or HBSS)-inoculated (a.c.) mice were euthanized at various times after intraocular injection, and their spleens were removed and snap-frozen in Tissue-Tek OCT compound (Sakura Finetek USA, Torrance, CA). The frozen spleens were sectioned at 4-m increments and stored at Ϫ20°C until ready for use. Following ice-cold acetone fixation, the tissue samples were immunostained with anti-F4/80-and Cy5-conjugated goat anti-rat IgG, anti-CD3⑀-, and Rhodamine-conjugated goat anti-Armenian hamster IgG, and biotinylated anti-NK1.1-and FITC-conjugated ExtrAvidin. After a final wash, the tissue sections were mounted with ProLong-AntiFade mounting media (Molecular Probes, Eugene, OR), protected with coverslips and stored at 4°C until analyzed by confocal microscopy. The immunofluorescence staining resulted in the appearance of F4/80 ϩ cells as bright pink, CD3⑀ ϩ cells as red/orange, conventional NK cells as green, and NKT cells as yellow (resulting from cancellation of the red/orange and green wavelengths).
Immunostained tissue sections were analyzed using a TCS 4D Confocal Laser Scanning Microscope (Leica, Deerfield, IL) fitted with a kryptonargon laser and three-color detection capability. The tissue sections were scanned at 15-25 sections/m, averaging 16 or 20 passes per section to obtain ultra-high-resolution images. Digital imaging and overlay of single and multicolor image stacks were done with Adobe Photoshop version 5.0 (Adobe Systems, Mountain View, CA).
Statistical analyses
All statistical analyses were performed by ANOVA with Neuman-Keuls post-hoc analyses. Significance was determined at p Յ 0.05.
Results
Tolerance-conferring macrophages selectively up-regulate MIP-2
Previous reports by Wilbanks and Streilein (12) showed that a presumably eye-derived ACAID-conferring monocyte/macrophage could be isolated from the bloodstream during the first week after a.c. inoculation of Ag and could transfer ACAID. We postulated that the macrophages that encounter Ag within the a.c. of the eye (a compartment rich in immunomodulatory factors) expressed a unique chemokine profile and that these chemokine-producing cells increased to detectable numbers in the bloodstream after inoculation of Ag (a.c.). In studies by Wilbanks and Streilein, ACAID-conferring cells (PBMCs) were more easily detected in 500 l of blood from a.c.-inoculated mice if the mice were splenectomized, presumably to prevent the exit of the cells to the spleen, thus enriching the circulating eye-derived F4/80 cell(s). In this report, instead of performing splenectomy, we collected and pooled the blood of five a.c.-inoculated mice to obtain detectable numbers of ACAID-conferring monocytes/macrophages from which RNA could be isolated.
Using a multiprobe RPA system, we observed that selective up-regulation of MIP-2 mRNA occurred in vivo among blood monocytes/macrophages after Ag (OVA) inoculation via the eye (a.c.), peaking at day 3 after Ag inoculation (Fig. 1A) . It should be noted that while MIP-2 increased in blood monocytes from a.c.-inoculated mice, other chemokines on the template either remained constant throughout the time course (i.e., MIP-1␣, MIP-1␤, and RANTES) or were not expressed (Ltn, eotaxin, MCP-1, and TCA-3). To compensate for slight variations in RNA loading from lane to lane, the bands were analyzed by scanning densitometry, and the chemokine gene expression was normalized to GAPDH levels. Densitometric analyses (Fig. 1B) confirmed that MIP-2 mRNA expression among PBMCs from a.c.-inoculated mice increased more than 2-fold at day 3 and returned to baseline by day 5 after a.c. inoculation. The appearance and disappearance of the MIP-2-producing cells in the blood coincides with the trafficking of ACAID-conferring PBMCs previously described by Wilbanks and Streilein (12) . Additionally, the selective induction of MIP-2 in PBMCs 3 days after a.c. inoculation of Ag did not occur following s.c. inoculation (data not shown). We also observed a slight increase in IP-10, which followed the same profile as MIP-2. Experiments are currently in progress to determine a role for IP-10 in ACAID.
In addition to examining chemokine mRNA expression in blood monocytes from mice that received OVA (a.c.), we also examined the chemokine profiles of the 59 and 63 macrophage hybridoma cell lines that when pulsed with Ag and transferred to naive recipients induced ACAID (tolerance) and Ag-specific suppression of DTH (18) . Macrophage hybridoma (59) cells were pulsed with Ag and exogenous TGF-␤2 (to mimic the high levels of intraocular TGF-␤2), whereas the 63 macrophage hybridoma cells were only pulsed with Ag because they synthesize TGF-␤ (18) . In examining the chemokine profiles of these cell lines, we found that, similar to the PBMCs from OVA-inoculated (a.c.) mice, ACAID-conferring 59 and 63 macrophages also selectively expressed increased amounts of MIP-2 mRNA, whereas non-ACAID-conferring macrophages did not (Fig. 2) . Together, these data suggest that in-FIGURE 2. Analysis of chemokine mRNA profile from ACAID-conferring macrophage cell lines. Total RNA was isolated from overnight cultures of 59 and 63 macrophage hybridomas in SFM containing OVA (5 mg/ml) and/or TGF-␤2 (5 ng/ml). Total RNA was isolated and subjected to multiprobe RPA using the RiboQuant system with the MCK-5 template set (A). MIP-2 mRNA expression was normalized to GAPDH expression for quantitation purposes, with the arbitrary OD units calculated as a ratio of MIP-2 to GAPDH expression (B). Data shown are representative of three experiments in which similar results were obtained. . PBMCs were obtained from the blood at 1, 3, 5, and 7 days after a.c. inoculation by density gradient centrifugation and processed to obtain total cellular RNA using TRIzol. Five micrograms of total RNA was then subjected to RiboQuant multiprobe RPA analysis using a riboprobe encoding multiple chemokine genes. The hybridization products were resolved on a polyacrylamide sequencing gel (A) and quantified by phosphorimaging. A bar graph (B) shows the results of scanning densitometry (n ϭ 5 per group). MIP-2 mRNA expression was normalized to GAPDH expression. Data shown are representative of two experiments in which similar results were obtained. Arbitrary OD units were calculated as a ratio of MIP-2 to GAPDH expression. Selected data for MIP-2 and MIP-1␣ are shown. Note that MIP-1␣ remains constant throughout the time course as did MIP-1␤ and RANTES (data not shown). No transcripts were detected for Ltn, eotaxin, MCP-1, or TCA-3.
creased
MIP-2 is a potent chemoattractant for NKT cells
Because the kinetics of MIP-2 mRNA expression and trafficking of ACAID-conferring APCs to the spleen seemed to herald the NKT cell accumulation in the spleen after OVA inoculation (a.c.), we postulated that MIP-2 was a chemoattractant signal for NKT cells. Results from Boyden chamber chemotaxis assays confirmed that freshly isolated FACS-sorted NKT cells, but not CD8 ϩ T cells, migrated along a concentration gradient of MIP-2 (Fig. 3B) . Evaluation of the cells on the Boyden chamber membranes by light microscopy showed that NKT cells incubated with recombinant murine (rm)MIP-2 exhibited marked morphologic changes. Many of the NKT cells found on the underside of the membrane were spindle-shaped, with prominent lamellipodia, morphology consistent with (but not restricted to) active migration or movement of the cells (Fig. 3A) .
Expression of CXCR2, the high-affinity receptor for MIP-2, was confirmed on FACS-sorted NKT cells by RT-PCR. The expression of a 555-bp RT-PCR product was observed in murine neutrophils and sorted NKT cells, but not in a fibroblast cell line or in FACSsorted CD8 T cells (Fig. 3C) . The modest expression of CXCR2 on NKT cells, compared with expression of CXCR2 mRNA in the neutrophil, may reflect a resting level or a response to manipulation and may not reflect the true level of receptor expression that occurs in stimulated NKT cells in vivo.
MIP-2 directs the migration of NKT cells to the spleen after a.c. inoculation of Ag
In comparing routes of Ag inoculation (a.c., i.v., or s.c.), we previously observed that only the a.c. route was associated with accumulation of NKT cells in the spleen (9) . Because MIP-2 was a chemoattractant for NKT cells and its expression increased selectively in the monocyte/macrophage population, presumably in transit from the eye to the spleen via the blood, we reasoned that blocking MIP-2 systemically following OVA inoculation (a.c.) would prevent the NKT cell accumulation in the spleen associated with ACAID. MIP-2 was neutralized with specific Abs in vivo. Mice were given OVA or HBSS (a.c.) and cotreated with either anti-MIP-2 mAb or rat IgG (i.p.) on days 0 and 4 after inoculation. Seven days after the initial a.c. inoculation and Ab treatment, splenic NKT cell frequency was determined by flow cytometry of whole splenocytes, as previously described (9) . Mice that received OVA (a.c.) and were cotreated with rat IgG displayed a 3-fold increase in the percentage and a 2-fold increase in the absolute number of splenic NKT cells, whereas a.c.-inoculated mice that were cotreated with anti-MIP-2 mAb showed no increase in NKT cells (Fig. 4) . Additionally, we noted that MIP-2 increased the percentage of NKT cells in the spleen, but not the percentage of either the CD3 or NK1.1 single-positive populations between experimental and control groups (Table I) . Administration of anti-MIP-2 mAb to HBSS-inoculated (a.c.) mice showed no effect on the baseline number of NKT cells present in the spleen (Fig. 4) . These data are in agreement with our previous observations that a small increase (from ϳ3% in naive mice to ϳ6% in a.c.-inoculated mice) in splenic NKT cells occurred after inoculation of OVA (a.c.) and was required to generate ACAID-regulatory T cells.
MIP-2-mediated recruitment of NKT cells to the spleen is required for the induction of CD8
ϩ Tr cells
Because NKT cells are crucial for the generation of CD8 ϩ Tr cells and the suppression of the effector phase of the DTH response, we determined whether blocking the recruitment of NKT cells to the spleen also blocked the generation of the Tr cell. Single-cell suspensions of spleen cells prepared from mice that received either OVA or HBSS (a.c.) in conjunction with anti-MIP-2 mAb or rat IgG (i.p.) were enriched for T lymphocytes (containing NKT cells) and used as regulatory cells in a LAT assay (9, 17) . In the LAT assay, all of the cells necessary for a localized DTH reaction (stimulator, effector) are injected into the ear pinna of a naive recipient mouse. The presence of Ag-pulsed APCs and Ag-primed effector T cells initiates the efferent arm of a local cellular immune response that can be quantified 24 or 48 h later by measuring the ear swelling. The ear of the recipient mouse acts, in effect, as a test tube, allowing the local DTH response to occur regardless of the recipient's immunologic status. The addition of regulatory cells to the inoculum tests their ability to suppress the local DTH response. Here, regulatory cells (enriched splenic T lymphocytes from experimental mice) were mixed with OVA-pulsed APCs (stimulators) and T cells enriched from spleens of OVA-primed mice (effector cells) and cotransferred into the ear pinnae of naive mice. Previously, we showed that Tr cells from OVA-inoculated (a.c.) mice, cotransferred with OVA-pulsed PECs and OVA-primed T cells, suppressed the local DTH response (9) . In contrast to regulatory cells obtained from mice inoculated with OVA (a.c.) and treated with rat IgG, T cells from spleens of mice inoculated with OVA (a.c.) and treated with anti-MIP-2 were unable to downregulate the adoptively transferred local DTH response (Fig. 5) . The inability to down-regulate a primed T cell response in the recipient's ear correlated positively with a statistically significant decrease in the number of NKT cells in the spleens of mice given OVA (a.c.) and treated with anti-MIP-2 mAb. Thus, in the absence of MIP-2, NKT cells were not recruited to the spleen, and CD8 ϩ Tr cells were not generated. These data extend our previous reports (9) that an increase in splenic NKT cells was associated with Ag inoculation into the eye by showing that NKT cell recruitment is mediated by MIP-2.
To further confirm the role for MIP-2 in recruiting NKT cells to the spleen after a.c. inoculation of OVA, mice that were genetically deficient in CXCR2, the high-affinity receptor for MIP-2, were inoculated (a.c.) with Ag. Seven days later, the spleens of CXCR2-deficient and wild-type (WT) a.c.-inoculated mice were collected, and single-cell suspensions of IMMULAN-enriched T cells were prepared. The enriched T cell populations were either used as regulator cells in the LAT assay or immunostained to determine NKT cell frequency by flow cytometry. Results were in agreement with the MIP-2-neutralizing Ab studies discussed above, in that a.c.-inoculated CXCR2-deficient mice showed no accumulation of NKT cells in their spleens and were unable to generate Ag-specific Tr cells (Fig. 6) . Untreated CXCR2-deficient mice also have fewer numbers of splenic NKT cells compared with WT mice, suggesting that MIP-2-CXCR2 interactions also may be important in either the basal trafficking of NKT cells to lymphoid organs or their development.
Splenic colocalization of NKT cells, F4/80
ϩ macrophages, and Tissue sections from mouse spleens 1 day after a.c. inoculation showed a typical splenic architecture comprised of T cell-rich areas (white pulp or PALS), red pulp, marginal zones (transition from red pulp to PALS, the site of Ag presentation), and reticular elements of the spleen (Fig. 7A) . In the frozen sections harvested 1 day post-a.c. inoculation, NK cells (green) were randomly scattered throughout the red pulp, whereas NKT cells (yellow) were rarely observed near the PALS. F4/80 ϩ cells were observed at a very low frequency in splenic tissue obtained from both naive B6 mice and sensitized mice 1 day after a.c. OVA. Also, F4/80 ϩ cells that were visualized in control sections were not associated with T cell areas or the marginal zone, but instead, as previously noted (19) , were found as isolated cells in the red pulp or in the subcapsular space, tightly associated with splenic reticular elements. Three days after OVA inoculation (a.c.), F4/80 ϩ cells appeared within marginal zones of the spleen (data not shown). However, 5-7 days post-OVA inoculation (a.c.), there was a marked increase in the number of F4/80 ϩ cells (bright pink) and NKT cells (yellow) within the marginal zones (Fig. 7, B and C) . As predicted from flow cytometric studies above correlating increases of NKT and F4/80 ϩ cells to the spleen after a.c. inoculation, NKT cells colocalized in the marginal zones with the F4/80 ϩ cells (bright pink) and conventional marginal zone T cells (orange) (Fig. 7, B-D) . Analyses of tissue sections 7 days post-a.c. inoculation were similar to day 5 in terms of cluster quantity and heterogeneity.
Discussion
To date, we have found only two isolated reports (20, 21) suggesting a role for any chemokines in either the induction or maintenance of immunologic tolerance and no reports of chemokinedirected migration of NKT cells. Given the importance of chemokines in the generation of conventional immune responses, inflammation, and wound healing, it is highly likely that chemokine-directed migration of specialized cell types is also required for the induction and/or maintenance of peripheral tolerance. Furthermore, it is plausible that defects in chemokine signaling could lead to inadequate tolerance induction. In support of this concept, this report shows that 1) ACAID-conferring monocytes/macrophages selectively up-regulated MIP-2, a functional murine homologue of human IL-8; 2) MIP-2 was a potent chemoattractant for NKT cells and selectively attracted NKT cells to the spleen during tolerance induction; 3) MIP-2-mediated chemoattraction of NKT cells was absolutely required for the generation of the Ag-specific negative Tr cells that convey peripheral tolerance and actively suppress DTH; and 4) in the absence of CXCR2, the high-affinity receptor for MIP-2, NKT cells failed to accumulate in the spleen after a.c. OVA as they did in WT controls.
Moreover, the data showed that MIP-2 mRNA was uniquely up-regulated in mononuclear cells that appeared in the blood following inoculation of Ag via the a.c. and in macrophage cell lines that exhibited the phenotype of eye-derived macrophages. Together, these data imply that eye-derived macrophages, in part, contribute to the production of MIP-2. Furthermore, because neutrophils were excluded from the density gradient preparations for PBMCs, and T cells do not generally produce MIP-2, we concluded that the cells of the monocyte/macrophage population found in the blood were those that produced MIP-2. Moreover, we found that the patterns of MIP-2 up-regulation coincided precisely with the trafficking of the ACAID-conferring cells from the blood to the spleen, as previously described by Wilbanks and Streilein (12) . As our results show, the level of MIP-2 mRNA expression rose nearly 3-fold among blood monocytes at day 3 and returned to baseline by day 7 after a.c. inoculation of Ag. In additional experiments, we observed that as MIP-2 disappeared from the blood monocyte population, its expression increased by 23.2% in the total splenic adherent cell population at day 7 (data not shown).
In studies extending work reported here, we have since identified the cellular source of MIP-2 mRNA as being F4/80 ϩ cells and observed by RT-PCR that F4/80 ϩ cells enriched from PBMCs and harvested from a.c.-inoculated mice expressed comparatively higher levels of MIP-2 mRNA than did enriched cells from i.v.-inoculated mice (manuscript in preparation). Furthermore, such data exclude the possibility of artifactual MIP-2 production due to endotoxin contamination of the Ag, OVA.
Because our previous data showed that NKT cells and F4/80 ϩ cells accumulated in the spleen after OVA was inoculated a.c. and were needed for the generation of the Tr cells (9), we predicted that NKT cells would interact not only with the APCs in the spleen, but also with the Tr cell precursor for the induction of peripheral tolerance and the development of the Tr cell. Indeed, histologic evidence showed the colocalization of at least three cells types (F4/ 80 ϩ APCs, NKT, and T cells) subsequent to the a.c. inoculation of Ag. It is well known that T cells, APCs, and B cells are in close association in the spleen and other lymphoid organs during the generation of primary Ab responses. This is the first evidence that a Data are expressed as mean percentage of total spleen cells Ϯ SEM, determined by flow cytometry of samples collected 7 days after treatment of the mice. The data shown are from three pooled experiments (15 mice per group). There were no significant differences found between groups as determined by ANOVA and Neuman Keuls post-hoc analysis.
the set of cells that is required to interact for tolerance induction is different from the set required for immune responses. Conventional wisdom previously suggested that the cells involved in tolerance might be the same as those for an immune response, but that the signals (soluble, cellular) might be different.
Although unknown, we predicted chemokines to be responsible for directing the trafficking of NKT cells to and from secondary lymphoid organs. Qin and colleagues reported several years ago that aside from its expression on neutrophils, the IL-8 receptor (CXCR2) was present only on a very small subpopulation of CD3 ϩ lymphocytes that coexpressed the NK marker, CD56 (22) . In a subsequent report, Wang and colleagues definitively showed that neither murine B220 ϩ , CD4 ϩ , nor CD8 ϩ cells stained positively with an anti-mouse IL-8 receptor homologue Ab, whereas a small subpopulation of NK1.1 ϩ cells did (23) . Although these reports suggested that NKT cells express the CXCR2 receptor, the data presented here definitively show that NKT cells respond and migrate preferentially along a chemotactic gradient of MIP-2, a murine functional IL-8 homologue. Additionally, we confirmed the mRNA expression of the high-affinity murine IL-8 receptor homologue, CXCR2, on NKT cells by RT-PCR (Fig. 3C ). In contrast to other chemokine receptors in both the CCR and CXCR families, murine CXCR2 exhibits little, if any, redundancy in its ligand binding in that it binds the only two known murine functional IL-8 homologues, MIP-2 and KC (24) . This suggests that in the mouse, only neutrophils and NKT cells respond to MIP-2. However, the data presented do not address the role of neutrophils in tolerance.
The origin of the F4/80 ϩ cells that accumulate with NKT cells in the splenic marginal zones subsequent to a.c. inoculation of Ag is presumed to be the eye, primarily by circumstantial evidence. Wilbanks and Streilein described a population of F4/80 ϩ cells that were indigenous to the iris and ciliary body (12) and also showed that OVA-pulsed PECs were capable of inducing ACAID if injected into the a.c. (12) . Given that F4/80 is a marker associated exclusively with professional APCs such as macrophages and dendritic cells (19, 25) , and that the Ag-bearing ACAID-conferring signal observed in the blood after a.c. inoculation is F4/80 ϩ (12), it was proposed that the APCs we observe in the marginal zone after a.c. inoculation of Ag included eye-derived APCs. It could be concluded from the confocal data that more F4/80 ϩ APCs were detected in the spleen 7 days post-a.c. inoculation than could have emigrated from the eye. Therefore, the potentially small numbers of eye-derived APCs may also influence the recruitment of additional F4/80 ϩ APCs and their ability to either induce or sustain tolerance. The exact origin of the NKT cells that accumulate in the spleen also remains undefined. It is possible that the NKT cells are sequestered in the spleen from the bloodstream after they emerge from NKT precursor cells in the bone marrow (26) or thymus (27) .
Although our studies focused on the interaction of NKT, F4/ 80 ϩ , and CD3 ϩ T cells during ACAID induction in the spleen, the results do not exclude the possibility of other cells being involved in the tolerance-inducing clusters. Both B cells (28) and perhaps ␥␦ cells (29) are required for ACAID induction, and it is known that CD4 ϩ and CD8 ϩ T cells differentiate into afferent and efferent regulatory cells as a result of these complex cellular interactions. Thus, the question is raised as to why so many cells are required to interact in ACAID-induced tolerance. The F4/80 ϩ cell and the B cell are potential APCs and could present Ag to different T cell populations, i.e., one may present to CD4 ϩ and the other to CD8 ϩ T cells. The NKT cell binds to the CD1d molecule that could be expressed by both conventional APCs and marginal zone B cells and could deliver amplifying signals (i.e., TGF-␤ and IL-10) to impose an environment that is regulatory cell promoting. Alternatively, the two APC populations could present to the same T cell populations but signal differently. Thus, unlike in the a.c., where cells are bathed in immunosuppressive aqueous humor, the observations reported here present evidence for a cell:cell-induced immunosuppressive microenvironment in the spleen.
Several reports in both mice and humans show that defective or deficient NKT cells correlate with the emergence of autoimmune disease (30 -32) , implying that NKT cells are crucial for maintaining peripheral self-tolerance. The precise effector mechanisms used by NKT cells to stave off autoimmunity are likely to involve soluble mediators such as IL-4, IL-10, and TGF-␤. Interestingly, this exclusive group of cytokines is involved in the induction of tolerance that is induced via immune-privileged sites, such as the eye, brain, and testis (10) . Our data support the possibility that certain forms of autoimmunity emerge because of a defect in the recruitment of CD1-reactive NKT cells to secondary lymphoid organs where active tolerance is induced. This defect could be at the level of the local APC that fails to recruit the appropriate cells to the secondary lymphoid organ. Bendelac and colleagues previously suggested that CD1 expression might serve to recruit NKT cells and activate them to release substantial amounts of immunomodulatory cytokines (33) . We propose that "tolerogenic" cytokines, such as TGF-␤, induce APCs to produce a selective set of chemokine(s) (as shown above) necessary for attraction of the CD1-restricted NKT cell to the site of tolerance induction. Interaction of NKT cells with CD1 on APCs leads to the release of an immunomodulatory cytokine that initiates the generation of CD8 ϩ Tr cells.
The unique data reported here show definitively that a specialized chemokine is associated with the movement of cells into secondary lymphoid organs during the activation and differentiation of negative regulatory cells required for peripheral tolerance and active suppression of DTH. In contrast to the cells that interact during immune activation (34) , this novel tolerance-inducing cell cluster in the marginal zone is, at the very least, dependent on MIP-2 secreted by tolerance-inducing APCs and on the recruitment of NKT cells for the generation of Tr cells. Although the magnitude and heterogeneity of cells within the cluster are yet to be defined, we can conclude that peripheral tolerance induced via an immune-privileged site is dependent on MIP-2-mediated recruitment of NKT cells.
